Clinical Trial Update: The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the pharmacokinetics and safety/tolerability of CKD-387 under fed conditions in Type 2 diabetes mellitus; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-387

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED